LOX-1 is involved in IL-1β production and extracellular matrix breakdown in dental peri-implantitis☆
Introduction
A dental implant is one of the most frequently used treatments for tooth replacement in patients [1]. Dental peri-implantitis, an oral inflammatory disease leading to supporting tissues loss, affects approximately 30% of patients [1], [2], [3], [4]. There are various treatment options for peri-implantitis [5], [6], [7], however, there does not appear to be one superior treatment approach proved to be highly effective against peri-implantitis thus far.
Tissues surrounding dental implants and teeth develop an inflammatory reaction in response to microbial infection, including P. gingivalis [8], [9], [10], Prevotella intermedia [11], [12], and Aggregatibacter actinomycetemcomitans [13], [14] infection. The human immune system responds to the bacterial infection by the recruitment of neutrophils, macrophages, T cells, and B cells into the lesion [15], [16], [17], [18]. Compared with periodontitis, peri-implantitis exhibits a more extensive inflammatory infiltrate of innate immunity, severe tissue destruction and faster progression [19], [20]. There have been multiple studies regarding the immunological pathogenesis of periodontal diseases, although the effects of innate immune responses to peri-implantitis have not been thoroughly evaluated [21].
Pattern recognition receptors (PRRs) play a vital role in innate immunity. Pathogen-associated molecular patterns (PAMPs) from microbial pathogens and damage-associated molecular patterns (DAMPs) from released cell components during cell damage or death have been identified by PRRs in innate immunity [22], [23]. Lectin-type oxidized LDL receptor 1 (LOX-1) (also known as oxidized low-density lipoprotein receptor 1, oxLDL receptor 1) is a pattern recognition receptor of the C-type lectin superfamily. In addition to being an oxLDL receptor, LOX-1 is a multi-ligand receptor which binds to activated platelets, apoptotic cells, C-reactive protein, and bacteria [24], [25], [26]. LOX-1 is also involved in P. gingivalis-induced atherosclerosis [27], [28], [29]. However, no previous studies have explored the role of LOX-1 in peri-implantitis.
The present report demonstrated that LOX-1, interleukin 1 beta (IL-1β), matrix metalloproteinase 2 (MMP2) and matrix metalloproteinase 9 (MMP9) were increased in peri-implantitis patients and in human THP-1 macrophages stimulated with P. gingivalis. The LOX-1 induced IL-1β production upon P. gingivalis infection was JNK dependent. Furthermore, LOX-1 also regulated MMP2 and MMP9 production induced by P. gingivalis. These results show that LOX-1 is essential for IL-1β production and extracellular matrix breakdown in peri-implantitis.
Section snippets
Peri-implant crevicular fluid (PICF) collection
This study was approved by the ethics committee of the Affiliated Hospital of Qingdao University and conducted in accordance with the Helsinki Declaration. Each patient provided informed consent.
The study population consisted of twenty patients (10 healthy implant patients and 10 peri-implantitis patients, with each patient having at least two dental implants).Two dental implants from each patient were evaluated in this study. All implants had been used for no less than two years.
LOX-1, IL-1β, MMP2 and MMP9 increased in peri-implantitis patients
LOX-1 production in peri-implantitiswas investigated by Western-blot and immunofluorescence staining. The western blot results indicated that protein levels of LOX-1 were significantly higher (P < 0.01) in PICF of peri-implantitis patients compared to healthy implants (Fig. 1A). LOX-1 was located mainly in the cell membrane of the superficial gingiva of peri-implantitis patients (Fig. 1B). In addition, the protein levels of IL-1β (Fig. 1C), MMP2 (Fig. 1D) and MMP9 (Fig. 1E) were elevated in PICF
Discussion
Peri-implantitis is an increasing problem associated with dental implants [38], [39]. Recently, the research attention of peri-implantitis has shifted from the microbiology and etiology to the host-response and inflammatory mediators involved. The initial host-response of infection is mediated by PRRs, which include C-type lectin receptors, Toll-like receptors, RIG-I-like receptors and NOD-like receptors [40]. To eradicate pathogens and infected cells, the expression of inflammatory mediators
References (58)
- et al.
Prevalences of peri-implantitis and peri-implant mucositis: systematic review and meta-analysis
J. Dent.
(2017) - et al.
Detection of five potentially periodontal pathogenic bacteria in peri-implant disease: a comparison of PCR and real-time PCR
Diagn. Microbiol. Infect. Dis.
(2016) Microbiological and immuno-pathological aspects of peri-implant diseases
Arch. Oral Biol.
(2014)- et al.
Innate immune function by toll-like receptors: distinct responses in newborns and the elderly
Immunity
(2012) - et al.
In silico identification of a therapeutic target for photo-activated disinfection with indocyanine green: modeling and virtual screening analysis of Arg-gingipain from Porphyromonas gingivalis
Photodiagn. Photodyn. Ther.
(2017) - et al.
Pattern recognition receptors and inflammation
Cell
(2010) - et al.
Porphyromonas gingivalis lipopolysaccharide induces pro-inflammatory adipokine secretion and oxidative stress by regulating toll-like receptor-mediated signaling pathways and redox enzymes in adipocytes
Mol. Cell. Endocrinol.
(2017) - et al.
Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors
Immunity
(2005) - et al.
Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion
Cell Host Microbe
(2010) - et al.
Coronary microembolization induces cardiomyocyte apoptosis through the LOX-1-dependent endoplasmic reticulum stress pathway involving JNK/P38 MAPK
Can. J. Cardiol.
(2015)
Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines
Pharmacol. Res.
The pathology of bone tissue during peri-implantitis
J. Dent. Res.
Surgical treatment of peri-implantitis intrabony lesions by means of deproteinized bovine bone mineral with 10% collagen: 7-year-results
Clin. Oral Implants Res.
Successful surgical protocols in the treatment of Peri-Implantitis: a narrative review of the literature
Implant. Dent.
Non-surgical treatment of peri-implant mucositis and peri-implantitis: a literature review
J. Clin. Periodontol.
Treatment modalities for peri-implant mucositis and peri-implantitis
Am. J. Dent.
Non-surgical therapy for Peri-implant diseases: a systematic review
J. Oral Maxillofac. Res.
Efficiency of nanotube surface-treated dental implants loaded with doxycycline on growth reduction of Porphyromonas gingivalis
Int. J. Oral Maxillofac. Implants
Bacterial colonization of the peri-implant sulcus in dentate patients: a prospective observational study
Clin Oral Investig
Peri-implant response and microflora in organ transplant patients 1 year after prosthetic loading: a prospective controlled study
Clin. Implant. Dent. Relat. Res.
Periodontal and peri-implant microbiota in patients with healthy and inflamed periodontal and peri-implant tissues
Clin. Oral Implants Res.
Antimicrobial effect of chlorhexidine on Aggregatibacter actinomycetemcomitans biofilms associated with peri-implantitis
J. Dent. Res. Dent. Clin. Dent. Prospects
Internal bacterial colonization of implants: association with peri-implant bone loss
Clin. Oral Implants Res.
Soft tissue response to titanium abutments with different surface treatment: preliminary histologic report of a randomized controlled trial
Biomed. Res. Int.
Basis of bone metabolism around dental implants during osseointegration and peri-implant bone loss
J. Biomed. Mater. Res. A
Metal elements in tissue with dental peri-implantitis: a pilot study
Clin. Oral Implants Res.
Peri-implant disease: what we know and what we need to know
J. Periodontal Implant Sci.
Peri-implant and periodontal microbiome diversity in aggressive periodontitis patients: a pilot study
Clin. Oral Implants Res.
Innate immune receptor expression in peri-implant tissues of patients with different susceptibility to periodontal diseases
J. Periodontol.
Cited by (17)
Vascular Biology of Arterial Aneurysms
2023, Annals of Vascular SurgeryYeast microcapsule-mediated oral delivery of IL-1β shRNA for post-traumatic osteoarthritis therapy
2021, Molecular Therapy Nucleic AcidsCitation Excerpt :IL-1β is one of the key genes involved in the pathogenesis of PTOA.7 It can promote the production of MMPs and enhance collagen and proteoglycan breakdown in cartilage.8,9 Previous study showed that viral-mediated IL-1R antagonist cDNA achieved disease-modifying effects via intra-articular administration.34,35
LOX-1 is involved in TLR2 induced RANKL regulation in peri-implantitis
2019, International ImmunopharmacologyCitation Excerpt :Mai Nakayachi et al. [41] found that the expression of RANKL, IL-1β and prostaglandin E2 evoked by the inflammation were reduced in LOX-1 deficiency mice. Our previous study found that LOX-1 involves in IL-1β production and extracellular matrix breakdown in peri-implantitis [24]. In present study, our data demonstrated that down-regulation of TLR2 or LOX-1 reduced RANKL expression in P. gingivalis stimulated THP-1 macrophages.
Peri-implantitis Diagnosis and Prognosis Using Biomarkers: A Systematic Literature Review
2023, International Journal of Oral and Maxillofacial Implants
- ☆
Fundings: This study was supported by the National Natural Science Foundation of China (81300730, 81500882) and Applied Basic Research Project of Qingdao (16-5-1-65-jch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.